Literature DB >> 25988662

Comments on "diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus".

Sven Otto1, Robert E Marx2, Matthias Tröltzsch1, Oliver Ristow3, Thomas Ziebart4, Bilal Al-Nawas4, Knut A Groetz5, Michael Ehrenfeld1, Valeria Mercadante6, Stephen Porter6, Alberto Bedogni7, Giuseppina Campisi8, Vittorio Fusco9, Ezher Dayisoylu10, Riham Fliefel1,11, Bente Brokstad Herlofson12, Christoph Pautke1, Tae-Geon Kwon13, Stefano Fedele14.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25988662     DOI： 10.1002/jbmr.2525

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN： 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  8 in total

1.  Definition and estimation of osteonecrosis of jaw (ONJ), and optimal duration of antiresorptive treatment in bone metastatic cancer patients: supplementary data from the denosumab extension study?

Authors:  Vittorio Fusco; Alberto Bedogni; Alfredo Addeo; Giuseppina Campisi
Journal:  Support Care Cancer       Date:  2016-03-09       Impact factor: 3.603

2.  Increased CD14+ and decreased CD14- populations of monocytes 48 h after zolendronic acid infusion in breast cancer patients.

Authors:  A Kyrgidis; M P Yavropoulou; R Lagoudaki; C Andreadis; K Antoniades; D Kouvelas
Journal:  Osteoporos Int       Date:  2016-11-17       Impact factor: 4.507

3.  Delayed Diagnosis of Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab Therapy in Colorectal Cancer Patients: Report of Two Cases.

Authors:  Francesco Erovigni; Alessio Gambino; Marco Cabras; Antonella Fasciolo; Silvio Diego Bianchi; Elisa Bellini; Vittorio Fusco
Journal:  Dent J (Basel)       Date:  2016-10-29

4.  Osteonecrosis of the Jaw (ONJ) in Osteoporosis Patients: Report of Delayed Diagnosis of a Multisite Case and Commentary about Risks Coming from a Restricted ONJ Definition.

Authors:  Mario Migliario; Giovanni Mergoni; Paolo Vescovi; Iolanda De Martino; Manuela Alessio; Luca Benzi; Filippo Renò; Vittorio Fusco
Journal:  Dent J (Basel)       Date:  2017-03-16

5.  Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures.

Authors:  Gioacchino Catania; Federico Monaco; Giulia Limberti; Manuela Alessio; Iolanda De Martino; Cecilia Barile; Antonella Fasciolo; Anna Baraldi; Marco Ladetto; Vittorio Fusco
Journal:  Dent J (Basel)       Date:  2016-12-01

6.  Metabolomic profiling reveals salivary hypotaurine as a potential early detection marker for medication-related osteonecrosis of the jaw.

Authors:  Wakako Yatsuoka; Takao Ueno; Kanako Miyano; Yasuhito Uezono; Ayame Enomoto; Miku Kaneko; Sana Ota; Tomoyoshi Soga; Masahiro Sugimoto; Toshikazu Ushijima
Journal:  PLoS One       Date:  2019-08-12       Impact factor: 3.240

Review 7.  Medication-Related Osteonecrosis of the Jaw (MRONJ): Are Antiresorptive Drugs the Main Culprits or Only Accomplices? The Triggering Role of Vitamin D Deficiency.

Authors:  Luca Dalle Carbonare; Monica Mottes; Maria Teresa Valenti
Journal:  Nutrients       Date:  2021-02-08       Impact factor: 5.717

8.  Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients?

Authors:  Giacomo Oteri; Giuseppina Campisi; Vera Panzarella; Ilaria Morreale; Riccardo Nucera; Olga Di Fede; Antonio Picone; Antonia Marcianò
Journal:  Biomed Res Int       Date:  2018-05-29       Impact factor: 3.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.